Unleashing the potential of global Britain for life sciences: Leading innovation, access and uptake
Join Public Policy Projects (PPP) and IQVIA for the second session in our webinar series ‘Unleashing the potential of global Britain for life sciences’.
The life sciences sector is the most productive and innovative sector in the UK, employing over 250,000 people and generating more than £75 billion for the economy. The Covid-19 pandemic has been a catalyst for hyper-accelerating clinical research through a new spirit of collaboration between government, industry, the NHS and patient organisations – but there remain challenges ahead.
This webinar will address the themes of innovation, access and uptake in the context of the UK leaving the EU and over a year of Covid-19. Before the pandemic, the access environment was not fit for purpose and resulted in inefficiencies which stunted progress. Post pandemic and Brexit, there is an opportunity to explore new processes and regulatory frameworks that allow patients to access innovative treatments and technologies as quickly and safely as possible. The NICE methods review and accelerated access collaborative are building momentum in this endeavour. However, the question remains: What must the UK to ensure it becomes a leader in the global landscape?
Angela McFarlane, Senior Market Development Director, IQVIA (Chair of session)
Professor Gillian Leng, Chief Executive, NICE
Matthew Whitty, Chief Executive, Accelerated Access Collaborative
Julia Dudley, Deputy Director, Innovation and Growth, Office for Life Sciences, DHSC/BEIS
David Peacock, Managing Director UK&I, MSD